CANDY WILLIAMS: Open Payments
NPI 1124483482 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,098 in 284 payments from 22 companies in 2025. Trend: 2023 $4,573 · 2024 $4,341 · 2025 $7,098
Food & beverage: $5,918Consulting: $1,080Education: $100
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 17 | $1,710 |
| ABBVIE INC. | 75 | $1,045 |
| Janssen Biotech, Inc. | 24 | $709 |
| Takeda Pharmaceuticals U.S.A., Inc. | 24 | $534 |
| Regeneron Healthcare Solutions, Inc. | 13 | $504 |
| PFIZER INC. | 23 | $461 |
| Phathom Pharmaceuticals, Inc. | 13 | $440 |
| Lilly USA, LLC | 13 | $295 |
| Ipsen Biopharmaceuticals, Inc | 17 | $291 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $212 |
Products named: REZDIFFRA, DUPIXENT, TREMFYA, RINVOQ, ENTYVIO, VOQUEZNA, OMVOH, IQIRVO.
Industry payments across OK — which companies pay providers there.
